Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
29.93 USD | +3.92% |
|
+10.89% | +39.34% |
02:34pm | Evercore ISI Starts Spyre Therapeutics With Outperform Rating | MT |
01/07 | Spyre Therapeutics, Inc.(NasdaqGS:SYRE) added to Russell Small Cap Comp Value Index | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+39.34% | 1.46B | |
+21.45% | 127B | |
+24.51% | 117B | |
+25.44% | 27.67B | |
-18.93% | 20.33B | |
-15.17% | 16.79B | |
-16.12% | 15.63B | |
+12.76% | 14.84B | |
-47.10% | 14.65B | |
+57.54% | 14.43B |
- Stock Market
- Equities
- SYRE Stock
- News Spyre Therapeutics, Inc.
- Evercore ISI Starts Spyre Therapeutics With Outperform Rating